Modifications

Aucun changement de taille ,  30 novembre 2018 à 14:38
m
aucun résumé des modifications
Ligne 87 : Ligne 87 :  
* 4. Food and Drug Administration. Devices@FDA. [Database: search on product code LSR]. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2014. Available at http://www.accessdata.fda.gov/scripts/cdrh/devicesatfda/index.cfmExternal Web Site Icon.
 
* 4. Food and Drug Administration. Devices@FDA. [Database: search on product code LSR]. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2014. Available at http://www.accessdata.fda.gov/scripts/cdrh/devicesatfda/index.cfmExternal Web Site Icon.
 
* 5. CDC. Notice to readers: recommendations for test performance and interpretation from the Second National Conference on Serologic * 6. Diagnosis of Lyme Disease. MMWR 1995;44:590–1.
 
* 5. CDC. Notice to readers: recommendations for test performance and interpretation from the Second National Conference on Serologic * 6. Diagnosis of Lyme Disease. MMWR 1995;44:590–1.
* 6. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005;18:484–509. <ref>https://www.ncbi.nlm.nih.gov/pubmed/16020686</ref> <ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1195970/<.ref>
+
* 6. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005;18:484–509. <ref>https://www.ncbi.nlm.nih.gov/pubmed/16020686</ref> <ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1195970/</ref>
    
== Références ==
 
== Références ==
6 958

modifications